Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov;7(6):405-11.
doi: 10.1093/inthealth/ihv032. Epub 2015 May 25.

Pregnant women with HIV in rural Nigeria have higher rates of antiretroviral treatment initiation, but similar loss to follow-up as non-pregnant women and men

Affiliations

Pregnant women with HIV in rural Nigeria have higher rates of antiretroviral treatment initiation, but similar loss to follow-up as non-pregnant women and men

Muktar H Aliyu et al. Int Health. 2015 Nov.

Abstract

Background: We examined antiretroviral therapy (ART) initiation and retention by sex and pregnancy status in rural Nigeria.

Methods: We studied HIV-infected ART-naïve patients aged ≥15 years entering care from June 2009 to September 2013. We calculated the probability of early ART initiation and cumulative incidence of loss to follow-up (LTFU) during the first year of ART, and examined the association between LTFU and sex/pregnancy using Cox regression.

Results: The cohort included 3813 ART-naïve HIV-infected adults (2594 women [68.0%], 273 [11.8%] of them pregnant). The proportion of pregnant clients initiating ART within 90 days of enrollment (78.0%, 213/273) was higher than among non-pregnant women (54.3%,1261/2321) or men (53.0%, 650/1219), both p<0.001. Pregnant women initiated ART sooner than non-pregnant women and men (median [IQR] days from enrollment to ART initiation for pregnant women=7 days [0-21] vs 14 days [7-49] for non-pregnant women and 14 days [7-42] for men; p<0.001). Cumulative incidence of LTFU during the first year post-ART initiation was high and did not differ by sex and pregnancy status. Persons who were unemployed, bedridden, had higher CD4+ counts, and/or in earlier WHO clinical stages were more likely to be LTFU.

Conclusions: Pregnant women with HIV in rural Nigeria were more likely to initiate ART but were no more likely to be retained in care. Our findings underscore the importance of effective retention strategies across all patient groups, regardless of sex and pregnancy status.

Keywords: Antiretroviral therapy; HIV/AIDS; Loss to follow-up; Nigeria; Retention in care.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Antiretroviral therapy (ART) initiation during the first 90 days after enrollment by gender and pregnancy status, Vanderbilt University/Friends in Global Health (VU/FGH) Nigeria Program, 2009–2013; (B) ART initiation among ART eligible clients during the first 90 days after enrollment by gender and pregnancy status, VU/FGH Nigeria Program, 2009–2013; (C) Cumulative incidence of loss to follow-up during the first 12 months following ART initiation by gender and pregnancy status at enrollment, VU/FGH Nigeria program (for individuals who were initiated on ART within 90 days of enrollment, n=2124). Solid line: pregnant females; dashed lines: nonpregnant females; dotted lines: males. This figure is available in black and white in print and in colour at International Health online.

References

    1. Heidari S, Abdool Karim Q, Auerbach JD, et al. Gender-sensitive reporting in medical research. J Int AIDS Soc 2012;15:11. - PMC - PubMed
    1. d'Arminio Monforte A, González L, Haberl A, et al. Women for Positive Action. Better mind the gap: addressing the shortage of HIV-positive women in clinical trials. AIDS 2010;24:1091–4. - PubMed
    1. Taking sex into account in medicine. Lancet 2011;378:1826. - PubMed
    1. Nicastri E, Leone S, Angeletti C, et al. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. J Antimicrob Chemother 2007;60:724–32. - PubMed
    1. Floridia M, Giuliano M, Palmisano L, Vella S. Gender differences in the treatment of HIV infection. Pharmacol Res 2008;58:173–82. - PubMed

Publication types

MeSH terms

Substances